Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Mesna × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Acute 5 Myelodysplastic Syndromes 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Lymphoma 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Teratoma 1 Sarcoma 1 Recurrence 1 Preleukemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasms 1 Meningeal Neoplasms 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphatic Diseases 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Prednisone 2 Cyclophosphamide 2 CT-P10 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Specimen Handling 1 Sirolimus 1 Pharmacogenomic Variants 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 Biopsy 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡